Derivation and Differentiation of Oligodendrocyte Progenitor Cells
Corresponding Organization :
Other organizations : University of Edinburgh, MRC Centre for Regenerative Medicine, Western General Hospital, UK Dementia Research Institute, Royal Edinburgh Hospital, Sanofi (France), Institute for Stem Cell Biology and Regenerative Medicine
Protocol cited in 2 other protocols
Variable analysis
- FGF2 20 ng/ml (PeproTech)
- PDGFα 20 ng/ml (PeproTech)
- Purmorphamine 1 μM (Calbiochem)
- SAG 1 μM (Calbiochem)
- IGF-1 10 ng/ml (PeproTech)
- Tri-iodothyronine (T3) 30 ng/ml (Sigma)
- Differentiation of oligodendrocytes
- Advanced DMEM/F12 containing: 1% N-2 supplement, 1% B27 supplement, 1% Anti-anti, 1% GlutaMAX (all from Life Technologies)
- Cells plated on 1/100 diluted Matrigel (BD Biosciences), 20 µg/ml Fibronectin (Sigma), and 10 µg/ml Laminin (Sigma) coated coverslips or plates at a density of 20,000–30,000 cells per 0.3 cm^2
- None specified
- Mitogen withdrawal (except for T3 and IGF-1) to achieve differentiation of oligodendrocytes
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!